article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Additional information regarding cannabinoids and pain appears online h ere.

article thumbnail

Report: Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis

Cannabis Law Report

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events.

Safety 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Medicinal cannabis users in the UK could be unfairly criminalised as study finds failures in roadside drug testing

Cannabis Law Report

The double-blind, randomised, placebo-controlled clinical trial took place over two years between 2017 and 2019 at the Center for Medicinal Cannabis Research at the University of California. medical cannabis users at risk of unfair prosecution, according to a report by Volteface.

article thumbnail

Cann Group (ASX:CAN) and Emyria (ASX:EMD) scrap CBD deal for other opportunities

Cannabis Law Report

Cann Group CEO Peter Crock said of the products: “Satipharm CBD capsules were one of the first medicinal cannabis products available to approved patients in Australia (under the Special Access Scheme) and have been successfully used in a variety of medical conditions since 2017.

CBD 105
article thumbnail

Cannabis Helps, Say Over Half of Parkinson’s Patients Who Use It

The Cannigma

Medical cannabis was legally approved in Germany in 2017 when approval was given for therapy-resistant symptoms in severely affected patients independent of diagnosis and without clinical evidence-based data,” lead investigator Professor Carsten Buhmann of the University Medical Center Hamburg-Eppendorf explained in a statement.

article thumbnail

Medical Marijuana Offers Hope for Treatment of PTSD

FloridaMarijuana.net

According to a 2017 report published by the National Academies of Sciences , PTSD is a stressor-related disorder which develops as a result of a patient’s exposure to a traumatic event. Medical marijuana and cannabinoids can be used to treat a patient’s physical and psychological health, alleviating the symptoms of PTSD.

Treatment 182
article thumbnail

New Study: Demographic and policy-based differences in behaviors and attitudes towards driving after marijuana use: an analysis of the 2013–2017 Traffic Safety Culture Index

Cannabis Law Report

We analyzed annual administrations of TSCI from 2013–2017, which asked respondents about various dimensions of traffic safety, including driving after marijuana use [ 28 ]. Between 2013 and 2017, approximately 3000 TSCI surveys were completed annually. 2017 Traffic Safety Culture Index: AAA Foundation for Traffic Safety; 2018.

Policy 59